Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nusinersen Effect on Ambulatory Function of Patients with Late-onset, Chronic SMA: A Multicenter, Prospective and Retrospective Observational Study

Next Previous
Trial Profile

Nusinersen Effect on Ambulatory Function of Patients with Late-onset, Chronic SMA: A Multicenter, Prospective and Retrospective Observational Study

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Feb 2019

At a glance

  • Drugs Nusinersen (Primary)
  • Indications Spinal muscular atrophy
  • Focus Therapeutic Use

    • Most Recent Events

    • 31 Jan 2019 Planned initiation date changed from 1 Dec 2018 to 7 Dec 2018.
    • 12 Dec 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top